China gives India competition in bulk drugs market

09/10/2013 | Business Standard (India)

China's exports of bulk drugs to India are growing at the rate of 30% annually, while Indian exporters are finding it difficult to enter the Chinese market, according to Indian pharmaceutical experts. Bulk drugs from China are growing in popularity because of price and availability, said Sunil Parekh of the global research company Crisil. Cheaper API imports from China are hurting domestic Indian API makers but may be a boon to generic drug companies.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX